- Report
- September 2026
- 197 Pages
Global
From €3271EUR$3,545USD£2,776GBP
€3635EUR$3,939USD£3,085GBP
- Report
- September 2026
- 199 Pages
Global
From €3271EUR$3,545USD£2,776GBP
€3635EUR$3,939USD£3,085GBP
- Report
- February 2026
- 250 Pages
Global
From €4143EUR$4,490USD£3,516GBP
- Report
- February 2026
- 250 Pages
Global
From €4143EUR$4,490USD£3,516GBP
- Report
- February 2026
- 250 Pages
Global
From €4143EUR$4,490USD£3,516GBP
- Report
- October 2026
- 177 Pages
Global
From €5398EUR$5,850USD£4,581GBP
- Report
- October 2026
- 372 Pages
Global
From €5398EUR$5,850USD£4,581GBP
- Report
- January 2026
- 185 Pages
Global
From €4152EUR$4,500USD£3,524GBP
- Report
- November 2025
- 185 Pages
Global
From €4152EUR$4,500USD£3,524GBP
- Clinical Trials
- May 2026
- 280 Pages
Global
From €2768EUR$3,000USD£2,349GBP
- Report
- February 2026
- 200 Pages
Global
From €7372EUR$7,990USD£6,257GBP
- Report
- May 2026
- 100 Pages
Global
From €2490EUR$2,699USD£2,114GBP
- Report
- April 2026
- 137 Pages
Global
From €3690EUR$3,999USD£3,132GBP
- Report
- August 2026
- 160 Pages
Global
From €3063EUR$3,320USD£2,600GBP
€3829EUR$4,150USD£3,250GBP
- Report
- October 2025
- 160 Pages
Global
From €2916EUR$3,160USD£2,475GBP
€3645EUR$3,950USD£3,093GBP
- Report
- October 2025
- 100 Pages
United States
From €5490EUR$5,950USD£4,659GBP
- Report
- September 2026
- 187 Pages
Global
From €3271EUR$3,545USD£2,776GBP
€3635EUR$3,939USD£3,085GBP
- Report
- September 2026
- 194 Pages
Global
From €3271EUR$3,545USD£2,776GBP
€3635EUR$3,939USD£3,085GBP
- Report
- February 2026
- 250 Pages
Global
From €4143EUR$4,490USD£3,516GBP
- Report
- February 2026
- 250 Pages
Global
From €4143EUR$4,490USD£3,516GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more